Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Method for preparing ceritinib

A technology of ceritinib and intermediates, which is applied in the field of preparation of ceritinib, can solve the problems of high cost, low yield, difficult industrialization and the like, and achieves the effects of low cost, simple operation and short synthesis route

Active Publication Date: 2015-02-18
安庆奇创药业有限公司
View PDF4 Cites 26 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] The purpose of the present invention is to overcome the shortcomings of the prior art such as low yield, difficulty in industrialization and high cost, and provide a chemical synthesis method of ceritinib with reasonable process, few steps, simple operation and high reaction yield

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing ceritinib
  • Method for preparing ceritinib
  • Method for preparing ceritinib

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Example 1: Preparation of 2-isopropylmercaptonitrobenzene

[0026] O-Fluoronitrobenzene (10g, 10mmol), add 100ml DMF, add 2-mercaptoisopropanol (5.4g, 70mmol), 25g potassium carbonate, warm to 100 degrees and react for 16h, cool to room temperature, add 500ml water, ethyl acetate (100ml*3) Extract, combine the organic layers, wash with water, wash with saturated brine, dry with anhydrous sodium sulfate, and concentrate to obtain 13.3g of light buttery substance, with a yield greater than 100%, without purification.

Embodiment 2

[0027] Example 2: Preparation of 2-(isopropylsulfonyl)nitrobenzene

[0028] O-Isopropyl mercaptonitrobenzene (13g, 65.97mmol), 120ml of dichloromethane, add m-chloroperoxybenzoic acid (25.67g, 149.42mmol) in batches at room temperature, stir at room temperature for 16h, filter, and concentrate to dryness to obtain a yellowish brown Solid 12g, yield 80%, not purified.

Embodiment 3

[0029] Example 3: Preparation of 2-(isopropylsulfonyl)aniline

[0030] 2-(isopropylsulfonyl)nitrobenzene (2g, 8.73mmol), add 30ml methanol, 0.2g 10% palladium on carbon, hydrogenate at atmospheric pressure for 6h, filter with suction, concentrate and spin off methanol to obtain 1.5g of light butter , The yield is 88%, without purification.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for preparing ceritinib, belonging to the field of chemical pharmacy. The method comprises the following steps: by taking 3-bromine-4-methylphenol as an initial raw material, performing phenolic hydroxyl isopropylation, nitration, coupling and reduction reaction, obtaining a midbody 1, by further taking o-nitro fluorobenzene as another initial raw material, performing isosulfhydrylation, oxidation, reduction and pyrimidine, obtaining a midbody 2, performing coupling reduction on the midbody 1 and the midbody 1, obtaining ceritinib which is protected by BOC acid anhydride, and finally removing a t-butyloxycarboryl protecting group, and obtaining ceritinib. The method is simple and feasible to operate, relatively high in yield, small in pollution and applicable to industrial production.

Description

Technical field [0001] The invention belongs to the field of chemical pharmacy, and specifically relates to a preparation method of ceritinib. Background technique [0002] Lung cancer is one of the main causes of cancer death. Non-small cell lung cancer (NSCLC) accounts for 85%-90% of lung cancer cases, and 2%-7% of cases are driven by the rearrangement of the ALK gene, which leads to the accelerated growth of cancer cells. Although the clinical treatment of ALK+NSCLC population has made significant progress, the deterioration of the disease is often inevitable, so more treatment options are needed. Xalkori is an inhibitor of degenerative lymphoma kinase (ALK), which was approved by the FDA in 2011 with accelerated approval and formally approved by the FDA in 2013. It is used in a test kit approved by the FDA to confirm that the tumor is anaplastic lymphoma. Treatment of patients with metastatic non-small cell lung cancer (NSCLC) with positive kinase (ALK). [0003] Xalkori is ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/12
CPCY02P20/55C07D401/12C07D211/26C07D239/42
Inventor 吴学平韩冬时珠勇
Owner 安庆奇创药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com